Janus Henderson Group PLC Ardelyx, Inc. Transaction History

Janus Henderson Group PLC

$182 Billion
Q2 2024

A detailed history of Janus Henderson Group PLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 25,949,323 shares of ARDX stock, worth $127 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

25,949,323

Previous 22,048,006 17.69%

Holding current value

$127 Million

Previous $161 Million 19.47%

% of portfolio

0.11%

Previous 0.09%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.89 - $9.31 $23 Million - $36.3 Million	3,901,317 Added 17.69%	25,949,323 $192 Million
Q1 2024 May 15, 2024	SELL	$6.05 - $9.74 $15.8 Million - $25.4 Million	-2,610,814 Reduced 10.59%	22,048,006 $161 Million
Q4 2023 Feb 14, 2024	SELL	$3.29 - $6.64 $8.63 Million - $17.4 Million	-2,623,801 Reduced 9.62%	24,658,820 $153 Million
Q3 2023 Nov 14, 2023	BUY	$3.3 - $4.83 $18 Million - $26.4 Million	5,455,941 Added 25.0%	27,282,621 $111 Million
Q2 2023 Aug 14, 2023	SELL	$3.23 - $4.95 $920,294 - $1.41 Million	-284,921 Reduced 1.29%	21,826,680 $74 Million
Q1 2023 May 15, 2023	BUY	$2.68 - $4.79 $6.26 Million - $11.2 Million	2,337,268 Added 11.82%	22,111,601 $106 Million
Q4 2022 Feb 14, 2023	BUY	$1.22 - $2.85 $14.1 Million - $32.8 Million	11,520,955 Added 139.59%	19,774,333 $56.4 Million
Q3 2022 Nov 14, 2022	BUY	$0.59 - $1.44 $4.87 Million - $11.9 Million	8,253,378 New	8,253,378 $9.86 Million
Q3 2021 Nov 16, 2021	SELL	$1.27 - $8.17 $740,241 - $4.76 Million	-582,867 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.55 - $8.98 $266,034 - $364,731	40,616 Added 7.49%	582,867 $4.42 Million
Q1 2021 May 17, 2021	BUY	$6.1 - $7.69 $1.25 Million - $1.58 Million	204,918 Added 60.75%	542,251 $3.59 Million
Q4 2020 Feb 16, 2021	BUY	$5.05 - $7.1 $1.7 Million - $2.4 Million	337,333 New	337,333 $2.18 Million

Others Institutions Holding ARDX

# of Institutions

214

Shares Held

144M

Call Options Held

977K

Put Options Held

1.41M

View Full List

About ARDELYX, INC.

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $756M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

More about ARDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Ardelyx, Inc. Transaction History